Compare NOVT & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NOVT | STVN |
|---|---|---|
| Founded | 1968 | 1949 |
| Country | United States | Italy |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Containers/Packaging |
| Sector | Miscellaneous | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.0B | 5.2B |
| IPO Year | 1999 | 2021 |
| Metric | NOVT | STVN |
|---|---|---|
| Price | $140.94 | $19.58 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 14 |
| Target Price | ★ $194.50 | $24.47 |
| AVG Volume (30 Days) | ★ 345.8K | 315.7K |
| Earning Date | 11-09-2026 | 11-03-2026 |
| Dividend Yield | N/A | ★ 0.32% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.82 | N/A |
| Revenue | ★ $521,290,000.00 | N/A |
| Revenue This Year | $15.57 | $6.96 |
| Revenue Next Year | $15.87 | $9.15 |
| P/E Ratio | $166.59 | ★ $27.15 |
| Revenue Growth | ★ 35.49 | N/A |
| 52 Week Low | $98.27 | $12.89 |
| 52 Week High | $176.38 | $27.00 |
| Indicator | NOVT | STVN |
|---|---|---|
| Relative Strength Index (RSI) | 50.01 | 45.30 |
| Support Level | $133.50 | $18.75 |
| Resistance Level | $144.65 | $20.02 |
| Average True Range (ATR) | 6.60 | 0.64 |
| MACD | -0.14 | 0.03 |
| Stochastic Oscillator | 47.29 | 44.59 |
Novanta Inc supplies core technology solutions to medical, life science, and advanced industrial OEMs, leveraging proprietary expertise in precision medicine, precision manufacturing, robotics and automation, and advanced surgery. It has two segments: Automation Enabling Technologies and Medical Solutions. Automation Enabling Technologies, which generates the majority of revenue, provides laser beam steering and scanning solutions, laser sources, and robotic and precision motion technologies. The Medical Solutions segment provides medical-grade technologies, including medical insufflators, endoscopic pumps, and integrated operating room technologies. The company operates in the United States, Germany, and other markets, with revenue generated from the United States.
Stevanato Group is a provider of glass and polymer drug containment, drug delivery, and diagnostic solutions to the pharmaceutical and life sciences industries. The company operates through two segments: a Biopharmaceutical and Diagnostic Solutions segment, which offers an integrated, end-to-end portfolio of products, processes, and services spanning the full drug lifecycle; and an Engineering segment, which designs, develops, and manufactures advanced machinery for pharmaceutical manufacturing, covering visual inspection, assembly and packaging, glass converting, and serialization. Stevanato's revenue is geographically diversified, with approximately 60% of sales generated in Europe, the Middle East, and Africa, 30% in North America, 8% in Asia-Pacific, and 2% in South America.